WPI 2345 (Lacosamide 200 mg)
Pill with imprint WPI 2345 is Blue, Elliptical/Oval and has been identified as Lacosamide 200 mg. It is supplied by Actavis Pharma, Inc.
Lacosamide is used in the treatment of seizures; epilepsy and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2345
Lacosamide
- Imprint
- WPI 2345
- Strength
- 200 mg
- Color
- Blue
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2345
More about lacosamide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (156)
- Drug images
- Pricing & coupons
- En español
- Drug class: miscellaneous anticonvulsants
Patient resources
- Drug Information
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
- Lacosamide Injection
- Lacosamide Oral Solution
- Lacosamide Tablets
- Other brands
- Vimpat
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.